Connect with us

Cannabis News

Is 57% the Weed Tipping Point?



57% tried weed

New Frontier Data released a May 2 report titled “Cannabis Consumers in America 2023: Part 1.” The study delves into the contemporary cannabis consumer’s diverse demographics and trends.


During a press release, Gary Allen, the CEO of New Frontier Data, claimed that more than  42% of adults who have consumed cannabis plan on using it again. Allen also explained that cannabis consumers fall under a broad range of genders, age groups, political affiliations, and economic backgrounds.


The increase in cannabis use can be attributed to more acceptance and openness towards cannabis use among Americans. This has created significant opportunities in new and emerging markets. As per the report, more than 42% of U.S. adults have used cannabis and are likely to repeat it, and an additional 15% have expressed their interest in trying cannabis in the future.


Details of The Survey

The survey was executed in the first quarter of 2023 with a sample size of 5,534 individuals. Among these individuals,  1,176 identified as non-cannabis users, while 4,358  identified as cannabis consumers.


Following the survey’s data, about 37% of American adults currently use cannabis and are grouped as “current consumers.” This group represents individuals that use cannabis at least once a year and plan on continuous usage. On the other hand, 30% claim to have never used cannabis and have no interest in trying it out. Interestingly, 15% of respondents were inclined to try cannabis for the first time, while 13% were former enthusiasts who have since sworn off consumption.


Meanwhile, New Frontier Data had previously analyzed American consumers in 2022. Comparing the results, the percentage of “current consumers” increased from 39% last year to 42% in 2023. On the other hand, the number of individuals who have never used cannabis and do not intend to do so decreased from 34% in the previous year to 30% in 2023.


The study analyzed responses from participants across various age groups regarding their cannabis consumption in the past month, from 2017 to 2021. The findings indicate an 8% decrease in cannabis use among adults aged 18 to 20 and a 20% increase among those aged 21 to 25 since 2017.


Increase in Cannabis Use

One crucial finding highlighted in the report is the increased cannabis usage in the last four years. The report shows that there’s been an increase of 96% in cannabis usage among individuals aged 65 and above. Cannabis usage among individuals aged 40 and 44 also increased by 64%. The report revealed that cannabis usage increased across all age groups except for adolescents within the 18 and 20 years age group.


With increased legalization, about 74% of Americans live in a cannabis-legalized state for medical or adult use. Of the 74%, 48% of these individuals live in states that permit adult cannabis use, while 26% live in states that legalized cannabis only for medicinal use.


Following the 2022 data on the legal cannabis market in the United States, cannabis buds retain the favourite spot among cannabis users, with a sales share of 43%. Vape holds the second position with a 29% sales share, followed by edibles and drinks (11%) and extracts (9%). The remaining 1% collectively represents tinctures, topicals and other products.


Focusing on the racial and ethnic diversity of cannabis consumers, the data gives fascinating insight. Cannabis consumers in the United States are distributed across white (63%), Black (14%), Hispanic/Latinx (14%), Asian (3%), Mixed/multi-racial (4%), and Other (2%). In terms of gender, men represent a more significant percentage, accounting for 54% of the population, while women account for the remaining 46%.


Cannabis Use for Specific Purpose

The study found that 70% of cannabis consumers use the substance for a specific purpose. The majority of consumers, approximately 83%, reported using cannabis to unwind and alleviate stress or anxiety, while 61% use it to improve their sleep quality.


The majority of cannabis consumers reported using the substance while engaging in activities such as video gaming (32%), socializing (33%), fun activities with family/partner (35%), eating (36%), surfing the internet (37%), sleeping (45%),  listening to music (52%), and watching television, videos, or movies at home (56%).


Additionally, some consumers reported using cannabis while doing household chores or housework (30%). Fewer than 30% reported using cannabis while cooking, spending time in nature, having sex, or drinking alcohol.


The majority of medical cannabis consumers use it to treat diagnosed conditions such as osteoarthritis (10%), PTSD (17%), migraines (21%),  and chronic pain (46%). Among all cannabis consumers, the most common reasons for use are inflammation (28%), insomnia (40%), depression (41%), anxiety (55%), and pain relief (64%). After consuming cannabis, 94% of consumers reported improving their medical conditions or symptoms.


Cannabis Dosage and Form

New Frontier Data reported that 77% of flower consumers consider strains important, while 47% prioritize minor cannabinoid and terpene profiles. Despite the growing attention to terpenes and minor cannabinoids, most consumers still rely on strains to make their purchasing decisions, as per the survey results.


The majority of edibles consumers prefer gummies, which make up 84% of the most common edibles, followed by cookies or brownies at 50%, chocolates at 42%, and beverages at 22%. When it comes to dosage, most consumers opt for 2-4 mg (14%), 5 mg (18%), or 10 mg (17%).


The first part of Cannabis Consumers in America 2023 is a comprehensive resource of valuable insights into current cannabis consumers. It comprises 45 pages of charts and data covering spending patterns, preferred purchasing locations, brand loyalty, social consumption habits, perspectives on policy, and much more.



The 2023 study on American cannabis consumers provides an in-depth analysis of cannabis use in today’s country. It outlines the crucial trends and advancements that the industry has seen over time. These include the rise in consumer numbers and the evolving preferences in product varieties and modes of consumption.



According to the report, a notable finding is that cannabis usage among Americans has risen from 39% in 2022 to 42% in 2023. The study further highlights a substantial increase in cannabis use among older age groups, with individuals aged 65 and above reporting a 96% increase and those in the 40 to 44 age bracket reporting a 64% increase.


With increased cannabis legalization, acceptance and usage across the United States, it will be fascinating to witness how consumer tastes and consumption habits change with time and how the industry adapts.





Source link

Continue Reading

Cannabis News

Will the 3rd Time be a Charm for Nebraska and Legalizing Medical Marijuana?




Nebraska legalizes medical marijuana

Nebraskans for Medical Marijuana, an organization formed by a state lawmaker in Nebraska, is optimistic that the third time will be the charm and that medical cannabis will be legalized in the state.


Nebraskans for Medical Marijuana (NMM) turned in two petitions to the secretary of state’s office on Thursday in an effort to start the 2024 election process as Sen. Anna Wishart’s (D) reform measure remains stuck in committee.


Nebraskans for Medical Marijuana’s Third Attempt


In Nebraska, proponents of the drug are attempting a third time to have voters decide the matter. They gathered sufficient signatures to get it on the 2020 ballot, but the state Supreme Court disqualified the proposal because of a legal issue with its single subject. They also failed to gather the necessary number of signatures for updated petitions in 2022 as a result of a large loss of essential money.


Co-chair of the NMM campaign, Crista Eggers, stated in a news release the need to consistently petition the government. She emphasized the Legislature’s defiance in the face of tremendous support from more than 80% of Nebraskans across political lines, geographic regions, and age brackets.


“We have consistently come up empty-handed after more than ten years of advocating, educating, and attempting to follow the right channels through our elected leaders in the Unicameral,” Eggers said. “As a result, we will once more turn to voting as our means of advancement.”


Regarding the newly submitted petitions, Senator Wishart confirmed that the language remains the same as in 2022. She mentioned that the Secretary of State’s office would legally review the petitions.


Renewed Efforts and Revised Petitions for 2024 Ballot


The senator’s proposed legislation on medical cannabis underwent a hearing in the Judiciary Committee of the unicameral legislature in February but has not made any progress. She attributes the lack of action to changes in membership and turnover within the committee. A previous bill version faced a filibuster in the Republican-controlled legislature, ultimately leading to its stagnation.


Regarding the 2024 ballot effort, Wishart expressed determination, stating that they would file again. She believes perseverance is vital to success; every setback they encounter only strengthens their resolve.



Wishart also highlighted their experience from the previous year, where they realized they didn’t have to rely solely on a major donor for success. She expressed optimism about their achievements with over a year of collection time. They gathered 180,000 signatures in just three months through a volunteer-led effort with limited resources.


One of the initiatives submitted by the campaign on Thursday aims to ensure legal protection for doctors who recommend cannabis and patients who use and possess it. The initiative focuses on patients and seeks to establish a state statute that exempts them from penalties under state and local law when they possess limited quantities of cannabis for medical purposes with a written recommendation from a healthcare practitioner. Additionally, it allows caregivers to assist qualified patients in these activities.


The second measure proposes the creation of the Nebraska Medical Cannabis Commission, which would be responsible for registering and regulating individuals involved in the possession, manufacturing, distribution, delivery, and dispensing of medical cannabis.


To prevent potential legal obstacles similar to the single-subject challenge that hindered the previous reform effort in 2020, the complementary proposals have been carefully designed to maintain a narrow focus. The aim is to ensure that each initiative addresses a specific subject matter, minimizing the chances of derailment.


Despite the disappointment caused by the Nebraska Supreme Court’s ruling on the single subject issue in 2020, Adam Morfeld, co-chair of NMM and a former Nebraska senator, emphasized that the ruling provided valuable guidance for refiling a new initiative. After thoroughly examining the court’s decision, the campaign has developed two new statutory initiatives that they are confident will meet constitutional requirements.


To secure a spot on the November 2024 ballot, the campaign needs to gather approximately 87,000 valid signatures for each petition and submit them by July 5, 2024. Activists have announced their plan to commence a signature drive at the beginning of June.


Following the setback faced in 2022 regarding medical cannabis, there were initial considerations of pursuing an adult-use legalization initiative. However, the current focus of the strategy seems to be solely on medical marijuana.


Lessons Learned and Ongoing Challenges


There are just three states without a medical cannabis program, including Nebraska. However, the National Conference of State Legislators claims that some states have low-THC programs.


State Senator Anna Wishart speculated that there might have been an error the first time.


She said, “they sold themselves short when we thought we had to wait for a major donor. They fell short by less than 10,000 signatures on the two petitions last year. We accomplished that with volunteers in three months. Imagine what we can achieve in a year and a half.


In 38 of Nebraska’s 93 counties, petitioners must also collect the signatures of 5% of the registered voters. They attempted to sue over that in the past but were unsuccessful.


Support from Medical Professionals and Patient Advocacy Groups


As a potential treatment for several medical problems, medical marijuana is receiving more and more support from physicians and other healthcare professionals. Medical professionals and patient advocacy organizations have significantly contributed to Nebraska’s current medical cannabis petition campaign. The campaign has received strong support from organizations like the Nebraska Medical Association and regional patient advocacy groups, who have highlighted the potential advantages of cannabis-based medicines for treating patients’ pain and enhancing their quality of life. Their backing gives the petition more authority and informs the public about medical cannabis’s therapeutic potential.


Nebraskans for Medical Marijuana improves their argument for legalization by working with healthcare providers and patient advocacy organizations, highlighting the medical necessity and beneficial effects on patients’ lives. These professionals’ engagement strengthens the campaign’s legitimacy and gives it a powerful voice in promoting compassionate and fact-based healthcare solutions.


Bottom Line

Nebraskans for Medical Marijuana is on its third attempt to legalize medical cannabis in Nebraska. Despite previous obstacles, the organization remains optimistic and determined in its pursuit. Supported by medical professionals, patient advocacy groups, and a dedicated team of volunteers, they aim to gather the required signatures to secure a place on the 2024 ballot. The proposed initiatives focus on safeguarding doctors and patients and establishing regulations for the medical cannabis industry. While challenges persist, the campaign draws inspiration from past experiences and the unwavering belief in the power of public support. Nebraskans for Medical Marijuana continues to advocate for the advancement of medical cannabis, fueling hope for its legalization in Nebraska.





Source link

Continue Reading

Cannabis News

New York Cannabis: The New True Party of Interest Rule




New York’s release of the revised adult-use rules and regulations has been well-publicized. A key revision that was the source of significant speculation was whether the Office of Cannabis Management (OCM) and Cannabis Control Board (CCB) would revise the True Party of Interest (TPI) definition with respect to ancillary service providers and the monetary limits before TPI status is triggered. And they did!

The revised TPI limits apply to the following parties:

  • Parties with risk sharing or goods and services agreements with the applicant/licensee;
  • Parties that consult and receive flat or hourly compensation from an applicant/licensee under a goods and services agreement; and
  • Goods and services provides that do not have any right to control the applicant/licensee.

Any party that falls under the aforementioned categories does not constitute a TPI as long as the payments in “that calendar year” do not “exceed the greater of”

  • 10% of the gross revenue of the applicant/licensee;
  • 50% of the net profit of the applicant/licensee; or
  • $250,00 from the applicant/licensee.

The key revision was increasing the dollar figure amount from $100,000 to $250,000, which will be particularly relevant to service providers to licensees in their first year(s) of operation, when gross revenue and/or net profit has the potential to be low.

Practically speaking, it will be interesting to see how the OCM actually applies this rule, given that gross revenue and net profit for a calendar year cannot actually be calculated until the end of the calendar year. It would not be surprising to see service providers structure contracts with a base compensation of $250 plus a year-end “true up” based on the licensee’s gross revenue or net profit.

We will keep working through the significant revisions to New York’s adult-use rules and regulations. Stay tuned!

Source link

Continue Reading

Cannabis News

The Cannabis Correlation – Every $1 Spent on Cannabis Leads to a Drop in Alcohol Sales of $0.75 to $0.85 Says New Canadian Study




weed correlation to booze sales

New Study Finds That Every Dollar Of Cannabis Sold Is Linked to a Reduction in Alcohol Sales

…. A Threat To Big Alcohol?


Big players in the alcohol industry have long been watching the development of legal cannabis with a careful eye, most especially with the launch of recreational cannabis markets in North America and beyond.


While some players in the alcohol industry see cannabis legalization as a threat, others see it as a special opportunity to develop new products and attract a new customer base. Customers themselves are becoming increasingly more educated about the harms of vices once thought as safe and normal – most especially alcohol consumption. The use of marijuana is already seen as normal in today’s society, and a safer substitute to alcohol.


Now, a recent study from Canadian researchers confirms that sales of medical marijuana are linked to a decrease in booze sales. The findings, which were published in the medical journal Health Policy, showed that medical marijuana legalization in Canada in particular may have prompted customers to substitute it for alcohol. The study was led by Professor Michael J. Armstrong of Brock University, who studied the sales of legal cannabis to those of wine, beer, and other liquor from 2015 through 2018 in Canada.

Specifically, he discovered that for every dollar of legal marijuana sold, there was a tie to declines in alcohol sales between 74 to 84 Canadian cents. Prof. Armstrong says the findings are not causative though it does suggest that alcohol is being replaced by cannabis. Additionally, he found that sales of alcohol from 2017 to 2018 were around 1.8% less than they would have been, had Canada not regulated medical cannabis.


“The negative association was robust to several alternative modeling choices,” he writes.


“From an academic perspective, this study found evidence that cannabis on average was a substitute, not a complement, for alcohol in Canada. This suggests cannabis might also have a substitution effect in other countries that legalize it, though that remains to be seen,” says Professor Armstrong in the paper.


“From a public health perspective, the results likewise imply that reductions in alcohol-related health impacts might partly offset the increased cannabis-related health impacts that legalization might bring,” he continues. “Furthermore, medical cannabis presumably improves the health of at least some patients by treating symptoms that alcohol had merely masked,” Armstrong says.


“Finally, from a political perspective, the results could make cannabis legalization slightly less attractive as financial policy but slightly less concerning as public health policy. This might influence legislative decisions in other countries that are considering legalization,” he adds.


Can Marijuana Substitute Alcohol?


Alcohol and marijuana are both mind-altering substances which have been used since ancient times by civilizations around the world for enjoyment. However, they are very different: consuming too much alcohol even just on one occasion or over a long period of time can result in serious health problems.


Alcoholism is a real problem in today’s society. Based on the 2021 National Survey on Drug Use and Health, almost 30 million people from ages 12 and up have experienced alcohol use disorder. Considering how widely available and easily accessible alcohol is, and the damage this can cause to families, our bodies, and society as a whole, these figures are downright shocking and scary.


Before discussing the use of marijuana as a substitute for alcohol, we must take note that anyone struggling with alcoholism or alcohol use disorder need to work with a medical professional to wean themselves off safely. Having a mental or physical dependency on alcohol is vastly different from an individual who merely wants to cut down on their drinking. You can also speak with a cannabis-knowledgeable doctor, if medical marijuana is legal in your state, about the possibility of integrating CBD into your therapy. There has been some research suggesting that CBD may indeed be useful for reducing alcohol cravings and helping individuals safely wean themselves off the drug.


That said, cannabis is a much safer substance compared to alcohol in more ways than one.


Alcohol alone is responsible for the deaths of 2.8 million each year around the world. Despite the research and illness we see caused by alcohol today, it is still among the leading causes for death and disability particularly cancer. It has been linked to around 60 chronic and acute diseases including heart disease, stroke, high blood pressure, breast cancer, dementia, and much more.


On the other hand, marijuana has never killed anyone. You can’t even overdose on cannabis. It’s significantly less addictive and less harmful, though possibilities of dependency still exist, but thousands of people around the world are able to consume cannabis responsibly. You can use pot instead of drinking wine at the end of a stressful day at work, to help you cope with everyday anxiety and depression, or even to help with chronic disease.




We do hope to see more studies verifying that cannabis sales result in less alcohol sales. This is only going to benefit society and our health as a whole.


But Big Alcohol doesn’t have to suffer the economic impact. If you can’t beat em, join em! And that’s what many alcohol companies are doing now: taking advantage of the opportunities presented by the growing trend of increased cannabis intake, by developing cannabis-infused beverages that merge the best of both worlds. Consumers also no longer have to choose between one or the other when you opt for a THC or CBD infused drink.





Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media